Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $191,034 - $217,602
1,800 New
1,800 $207,000
Q1 2022

May 17, 2022

SELL
$80.11 - $90.62 $1.96 Million - $2.22 Million
-24,500 Reduced 60.49%
16,000 $1.4 Million
Q4 2021

Feb 15, 2022

SELL
$79.7 - $88.13 $1.35 Million - $1.49 Million
-16,900 Reduced 29.44%
40,500 $3.54 Million
Q3 2021

Nov 16, 2021

BUY
$81.78 - $95.14 $507,036 - $589,868
6,200 Added 12.11%
57,400 $4.69 Million
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $2.82 Million - $3.12 Million
-33,100 Reduced 39.26%
51,200 $4.67 Million
Q1 2021

May 18, 2021

SELL
$83.5 - $98.47 $2.01 Million - $2.37 Million
-24,100 Reduced 22.23%
84,300 $7.21 Million
Q4 2020

Feb 17, 2021

BUY
$78.07 - $94.43 $1.78 Million - $2.15 Million
22,800 Added 26.64%
108,400 $10.2 Million
Q3 2020

Nov 17, 2020

BUY
$82.14 - $91.0 $1.34 Million - $1.48 Million
16,300 Added 23.52%
85,600 $7.44 Million
Q2 2020

Aug 17, 2020

BUY
$80.93 - $91.1 $1.85 Million - $2.09 Million
22,900 Added 49.35%
69,300 $6.05 Million
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $2.4 Million - $3.36 Million
33,900 Added 271.2%
46,400 $3.83 Million
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $1.21 Million - $1.36 Million
-14,300 Reduced 53.36%
12,500 $1.18 Million
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $1.4 Million - $1.55 Million
16,400 Added 157.69%
26,800 $2.33 Million
Q2 2019

Aug 15, 2019

SELL
$75.4 - $92.8 $286,520 - $352,640
-3,800 Reduced 26.76%
10,400 $950,000
Q4 2018

Feb 15, 2019

SELL
$73.66 - $82.02 $537,718 - $598,746
-7,300 Reduced 33.95%
14,200 $1.22 Million
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $354,782 - $410,379
5,300 Added 32.72%
21,500 $1.85 Million
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $746,134 - $891,990
10,600 Added 189.29%
16,200 $1.31 Million
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $415,184 - $432,712
5,600
5,600 $481,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.